Cure My Disease

Don't miss your cure!

 Log in / Sign up

Can monthly selfies and symptom logs reveal how chronic skin diseases flare and settle?

NCT ID NCT07804134

Knowledge-focused Sponsor: Medisch Spectrum Twente Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting This study
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Sep 04, 2026 · Last updated Sep 04, 2026

Summary

This study builds a long-term research cohort for people with psoriasis, eczema, or hidradenitis suppurativa. Participants use a certified app to answer symptom questions and take standardized photos of their skin once a month, with longer questionnaires twice a year. Trained assessors score the photos for disease severity, and the data are combined with routine care records, pharmacy dispensing data, and local environmental measurements. The goal is to understand how these conditions change over time, what precedes flares, and how treatment and environment relate to disease course, while also creating a dataset for future AI tools.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
No drug or treatment is tested. Participants use a digital health app to submit monthly symptom questionnaires and standardized skin photos from home.
What this could lead to
If successful, this could create a large dataset to help develop AI tools that assess skin disease severity from photos, and enable future studies of digital care innovations.
What could go wrong
This is an observational cohort, not a treatment trial, so it won't directly change care. The accuracy of home photos and self-reported symptoms may vary, and AI development is exploratory.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Participants

About 1,000 people

The number the study aims to enrol. It can still change while the study runs.

Expected to start

Oct 2026

An estimate. Start dates often move.

Expected to finish

Sep 2036

An estimate. End dates often move.

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Who is studied

The study population consists of patients of above 16 years old with a chronic inflammatory skin disease who are under treatment at the dermatology department of MST or ZGT at the time of inclusion. Eligible patients are informed about the study during a routine outpatient visit at the dermatology department. Participation is voluntary, and informed consent is obtained prior to inclusion, via the app.

Ages

16 years and older

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Diagnosis of a chronic inflammatory skin disease (psoriasis, atopic dermatitis, hidradenitis suppurativa), as determined by the treating dermatologist. * Currently receiving dermatological care at Medisch Spectrum Twente (MST) or Ziekenhuisgroep Twente (ZGT) at the time of inclusion. * Willing and able to participate in longitudinal monitoring, including completion of questionnaires and submission of standardized photographs. * Sufficient command of the Dutch language to understand the study information and to complete questionnaires. Exclusion Criteria: * The patient has insufficient command of the Dutch language resulting in the insufficient ability to understand and/or answer questions

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Eczema atopic dermatitis are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

atopic eczema Eczema hidradenitis suppurativa psoriasis

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Eczema atopic dermatitis Hidradenitis suppurativa (HS) Psoriasis

How to take part

Only the study team decides who joins. These are the ways to reach them.

  1. The places running it

    3 sites. The list below names each one and where it is.

  2. The official record

    ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.

    Open the record ↗

  3. A doctor treating you

    A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.

Contacts and locations

Locations

  • Medisch Spectrum Twente

    Enschede, Overijssel, 7512KZ, Netherlands

  • Ziekenhuisgroep Twente

    Almelo, Overijssel, 7609PP, Netherlands

  • Ziekenhuisgroep Twente

    Hengelo, Overijssel, 7555 DL, Netherlands

More trials for these conditions

Other studies related to the condition(s) this trial covers.